145 related articles for article (PubMed ID: 15705981)
1. The role of whole-body bone scanning and clinical factors in detecting bone metastases in patients with non-small cell lung cancer.
Erturan S; Yaman M; Aydin G; Uzel I; Müsellim B; Kaynak K
Chest; 2005 Feb; 127(2):449-54. PubMed ID: 15705981
[TBL] [Abstract][Full Text] [Related]
2. Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning.
Michel F; Solèr M; Imhof E; Perruchoud AP
Thorax; 1991 Jul; 46(7):469-73. PubMed ID: 1652164
[TBL] [Abstract][Full Text] [Related]
3. Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection--pilot study.
Earnest F; Ryu JH; Miller GM; Luetmer PH; Forstrom LA; Burnett OL; Rowland CM; Swensen SJ; Midthun DE
Radiology; 1999 Apr; 211(1):137-45. PubMed ID: 10189463
[TBL] [Abstract][Full Text] [Related]
4. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.
Cheran SK; Herndon JE; Patz EF
Lung Cancer; 2004 Jun; 44(3):317-25. PubMed ID: 15140545
[TBL] [Abstract][Full Text] [Related]
5. Can clinical factors be determinants of bone metastases in non-small cell lung cancer?
Ursavas A; Karadag M; Uzaslan E; Rodoplu E; Demirdögen E; Burgazlioglu B; Gozu RO
Ann Thorac Med; 2007 Jan; 2(1):9-13. PubMed ID: 19724668
[TBL] [Abstract][Full Text] [Related]
6. Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer.
Schirrmeister H; Arslandemir C; Glatting G; Mayer-Steinacker R; Bommer M; Dreinhöfer K; Buck A; Hetzel M
Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):964-8. PubMed ID: 14991241
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive staging of non-small cell lung cancer: a review of the current evidence.
Toloza EM; Harpole L; McCrory DC
Chest; 2003 Jan; 123(1 Suppl):137S-146S. PubMed ID: 12527573
[TBL] [Abstract][Full Text] [Related]
8. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
9. Staging non-small cell lung cancer with whole-body PET.
Marom EM; McAdams HP; Erasmus JJ; Goodman PC; Culhane DK; Coleman RE; Herndon JE; Patz EF
Radiology; 1999 Sep; 212(3):803-9. PubMed ID: 10478250
[TBL] [Abstract][Full Text] [Related]
10. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
Aquino SL; Fischman AJ
Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
[TBL] [Abstract][Full Text] [Related]
11. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
[TBL] [Abstract][Full Text] [Related]
12. [Recent status of the diagnosis and treatment of bone metastasis in patients with advanced lung cancer].
Eguchi K; Saijo N; Shinkai T; Sasaki Y; Tamura T; Sakurai M; Oyamada H; Terui K; Fukuma H; Beppu Y
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1696-703. PubMed ID: 3036014
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of pentavalent Tc-99m DMSA scintigraphy in small cell and nonsmall cell lung cancers.
Atasever T; Gündoğdu C; Vural G; Kapucu LO; Karalezli A; Unlü M
Nuklearmedizin; 1997 Oct; 36(7):223-7. PubMed ID: 9394361
[TBL] [Abstract][Full Text] [Related]
14. [MRI in the early diagnosis of spinal metastases of bronchial cancer].
Sauvage PJ; Thivolle P; Noël JB; Dagognet J; Quipourt V; Auberger R; Maréchal F; Robert J
J Radiol; 1996 Mar; 77(3):185-90. PubMed ID: 8830142
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging.
Burt M; Heelan RT; Coit D; McCormack PM; Bains MS; Martini N; Rusch V; Ginsberg RJ
J Thorac Cardiovasc Surg; 1994 Feb; 107(2):584-8; discussion 588-9. PubMed ID: 8302078
[TBL] [Abstract][Full Text] [Related]
16. FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy.
Eschmann SM; Friedel G; Paulsen F; Budach W; Harer-Mouline C; Dohmen BM; Bares R
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):804-8. PubMed ID: 12029555
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of bone-specific alkaline phosphatase for bone metastases detection in prostate cancer].
Rasch-Isla Muñoz A; Cataño Cataño JG
Arch Esp Urol; 2004 Sep; 57(7):693-8. PubMed ID: 15536950
[TBL] [Abstract][Full Text] [Related]
18. [The value of skeletal scintigraphy in the aftercare of breast carcinoma. A prospective study of 750 cases].
Schünemann H; Jourdain M
Dtsch Med Wochenschr; 1989 Jan; 114(1):3-8. PubMed ID: 2535982
[TBL] [Abstract][Full Text] [Related]
19. [Is short-term follow-up by skeletal scintigraphy of use in deciding on curative irradiation of inoperable non-small cell bronchial carcinoma? The experiences with 363 cases].
Broemel T; Bünemann H
Strahlenther Onkol; 1989 Jan; 165(1):43-6. PubMed ID: 2536963
[TBL] [Abstract][Full Text] [Related]
20. [Bone evaluation in microcellular cancer treated by chemotherapy].
Seigneur J; Albrecht N; Feintrenie X; Chambre JF; Lamy P
Rev Pneumol Clin; 1985; 41(6):365-74. PubMed ID: 3010429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
